Mesalazine didn’t help diarrhea-predominant IBS

CHICAGO – Treating diarrhea-predominant irritable bowel syndrome with mesalazine for 12 weeks failed to improve stool frequency or other symptoms, compared with placebo, in a multicenter, randomized...

Field of Interest: Gastroentero...
Type: News Item

Statins linked to lower physical activity

Initiating statin therapy in older men was associated with a modest but significant drop in physical activity, according findings from a large, observational study published online June 9 in JAMA...

Field of Interest: Gastroentero...
Type: News Item

Azathioprine, anti-TNF monotherapy safe in IBD pregnancy

CHICAGO – Women with inflammatory bowel disease can safely continue monotherapy with azathioprine/6-mercaptopurine or antitumor necrosis–alpha agents during pregnancy to maintain remission, according...

Field of Interest: Pulmonology
Type: News Item

Tests may help before liver transplant, not after

CHICAGO – Two laboratory measurements that are commonly used to assess the cause of symptomatic ascites before liver transplant may be deceptive when used to assess posttransplant ascites, a...

Field of Interest: Gastroentero...
Type: News Item

Ramosetron offers IBS-D alternative

Once-daily ramosetron improved stool consistency in male patients with diarrhea-predominant irritable bowel syndrome, Dr. Shin Fukudo and colleagues reported in the June issue of Clinical...

Field of Interest: Gastroentero...
Type: News Item

Diet modifications highly effective in EoE

An elemental diet was more than 90% effective in inducing histologic remission in eosinophilic esophagitis patients, reported Dr. Ángel Arias and colleagues in the June issue of...

Field of Interest: Gastroentero...
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness